IL1B and adenocarcinoma: Adenocarcinomas were more frequent in Q1 (lowest IL-1β expression) than Q4 (72.2% vs. 44.3%, p < 0.001), while squamous cell carcinomas (SCCs) were more common in Q4 (12.1% vs. 36.4%, p < 0.001).